This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bar-Ilan University, Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2026.
Company Filing History:
1 out of 244 
1 out of 910 
Years Active: 2026
Title: Yossi Mandel - Innovator in Ocular Angiogenesis Research
Introduction
Yossi Mandel is an inventor based in Givataim, Israel. He has made significant contributions to the field of ocular angiogenesis, focusing on the development of innovative solutions for ophthalmological conditions. Although he currently holds no granted patents, his work is noteworthy for its potential impact on medical science.
Latest Patent Applications
Yossi Mandel's latest patent application is titled "Conjugates Comprising Ocular Angiogenesis Growth Factor Aptamers and Uses Thereof in the Detection and Treatment of Ophthalmological Angiogenesis Indications." This application describes an antiangiogenic agent in the form of a vehicle, such as a nanoparticle, associated with at least one ocular angiogenesis growth factor aptamer. The association is designed to be labile to interaction between the aptamer and an ocular angiogenesis growth factor, highlighting the innovative approach he is taking in this area of research.
Conclusion
Yossi Mandel's work in ocular angiogenesis research demonstrates his commitment to advancing medical science, even in the absence of granted patents. His innovative ideas and applications have the potential to contribute significantly to the treatment of ophthalmological conditions.